<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-H318RJWT</identifier><date>2005</date><creator>Kristan, Katja</creator><creator>Lanišnik-Rižner, Tea</creator><relation>documents/znanstveni_clanki/farmacevtski_vestnik/html/urn_nbn_si_doc-h318rjwt.html</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/pdf/urn_nbn_si_doc-h318rjwt.pdf</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/txt/urn_nbn_si_doc-h318rjwt.txt</relation><format format_type="main">10 strani</format><format format_type="issue">3</format><format format_type="volume">56</format><format format_type="type">article</format><format format_type="extent">str. 259-268</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">20222169</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-H318RJWT</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">androgeni</subject><subject language_type_id="slv">biosinteza</subject><subject language_type_id="slv">estrogeni</subject><subject language_type_id="slv">hormoni</subject><subject language_type_id="slv">inhibitorji</subject><title>17beta-hidroksisteroid-dehidrogenaze - obetajoče farmakološke tarče</title></Record>